Creative Planning
KYNB

Creative Planning’s Kyntra Bio KYNB Stock Holding History

Creative Planning’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-31
Closed -$25K – 2495
2017
Q2 		$25K Buy
31
+5
+19% +$3.48K ﹤0.01% 3019
2017
Q1 		$16K Hold
26
– – ﹤0.01% 3273
2016
Q4 		$14K Hold
26
– – ﹤0.01% 3311
2016
Q3 		$14K Hold
26
– – ﹤0.01% 3273
2016
Q2 		$11K Buy
26
+4
+18% +$1.83K ﹤0.01% 3171
2016
Q1 		$11K Hold
22
– – ﹤0.01% 3154
2015
Q4 		$16K Buy
22
+18
+450% +$11.9K ﹤0.01% 2979
2015
Q3 		$2K Buy
+4
New +$2.42K ﹤0.01% 3930
2015
Q2 		– Sell
-4
Closed -$3K – 1731
2015
Q1 		$3K Hold
4
– – ﹤0.01% 3734
2014
Q4 		$3K Buy
+4
New +$2.57K ﹤0.01% 3695

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Creative Planning's KYNB Position: Q3 2017 in Review

Creative Planning sold out of Kyntra Bio (KYNB) in Q3 2017, closing a stake of 31 shares — an estimated $25K sold.

Creative Planning first reported a position in KYNB in Q4 2014 and held it in 10 quarters. The position peaked at $25K in Q2 2017. 182 funds tracked by Wall St. Rank hold KYNB as of Q3 2017.

  • Creative Planning reported no remaining Kyntra Bio position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 31 Kyntra Bio shares in Q3 2017, an estimated $25K.
  • Creative Planning first reported a position in Kyntra Bio in Q4 2014 and held it in 10 quarters.
  • Creative Planning's Kyntra Bio position peaked at $25K in Q2 2017.
  • 182 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.